Scangos to remain PhRMA chair for now

In a statement, PhRMA said George Scangos will remain its chairman until he leaves Biogen Inc. (NASDAQ:BIIB) or until his current term ends in March 2017. Scangos said Thursday he will step down as Biogen's CEO "sometime within the next few months" after the company names a successor (see above). ...